Trust Through Transparency
Trust is a precious thing, and building trust takes hard work—especially in the healthcare sector. Click here to learn more about how we build trust.
Search
Innovation Needs Transparency
At Boehringer Ingelheim, we prioritise the establishment and maintenance of public trust. Transparency is therefore a key pillar of our corporate culture.
Accountability
Even in ambiguous circumstances, we always demonstrate ownership for our decisions and actions. Click here to learn more about accountability at BI.
More Potential Overview
More Potential works to provide the best conditions for our people, communities and partners along our value chain. Click here to find out more.
Bringing Precision to Psychiatry
Dr Hugh Marston and Dr Vikas Mohan Sharma discuss how precision psychiatry can enable people living with mental health conditions to thrive. Learn more.
Poultry farming drives sustainability
The Village Poultry Project & Making More Health strive to make poultry farming sustainable. Click here to find out more information about this.
Partnering for innovation and growth
In this interview Dr Frerich de Vries talks about why partnerships are one of the key areas of interest for Boehringer Ingelheim and more. Learn more.
COVID-19 Bill and Melinda Gates Foundation
We are joining the COVID-19 Therapeutics Accelerator of the Bill and Melinda Gates Foundation to fight the pandemic. Click here to learn more.
Stroke, Don’t Stay at Home
During COVID-19, there was a decrease in stroke hospital admissions. Learn why it is crucial that patients can still access urgent care at this time.
COVID-19 Volunteering in Mexico
Sonia Angulo, Medical Representative of Human Pharma in Mexico, has become a hero for many health workers who are facing the COVID-19 pandemic. Learn more.
The Core of our Leitbild
Click here to find out about the core of our leitbild. Here you can find out information about who we are and what we strive for at Boehringer Ingelheim.
EMPRISE
Learn about the EMPRISE real-world evidence study and use of empagliflozin in routine clinical care. Click here to find out more information.
Donations of Protective Materials to Healthcare Institutions
Boehringer Ingelheim Mexico donated protective materials to governmental health institutions dedicated to the care of patients with COVID-19. Learn more.
Accountability, Agility, Intrapreneurship
At Boehringer Ingelheim we work together with accountability, agility, and intrapreneurship. Click here to read about what this means for us here.
COVID-19 Spain - Volunteering for good causes in Spain
Three Boehringer Ingelheim employees in Spain have stepped forward to help out during the COVID-19 pandemic. Click here to find out and learn more.
World Water Day: Good Health Hinges on Good Water
Water availability and quality affects many aspects of individual, societal and environmental health. Good health hinges on good water. Learn more here.
Rare Diseases: Rare but not alone
We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies. Click here to find out more about our work.
COVID-19 Southeast Asia Support of Healtvare Community
Learn more about what Boehringer Ingelheim is doing to assist health workers in managing the pandemic in Southeast Asia. Click here to find out more.
Interconnected CRM conditions
Learn about the interconnectivity between the heart, kidney and metabolic systems with this animation featuring the members of the Harold Heart household.
One step further in fighting rabies in Vietnam
A expedition team set off to the Duc Hue District. The purpose? To vaccinate the entire dog and cat population of several villages. Find out more.ral villages.
Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state
Boehringer Ingelheim India signs MoU with the Government of Maharashtra, to strengthen stroke care in the state
COVID-19 In Colombia we support integrally
At Boehringer Ingelheim Colombia, we are caring for those in the most vulnerable situations during COVID-19. Click here to learn more about our work.
Biberach
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Biberach site.
COVID-19 IMI2–Call 21
CARE launched to accelerate therapy development against COVID-19 and future coronavirus threats.
Our Commitment
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals. Find out more.